Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...

UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland. The ...

OTTAWA, ON / ACCESSWIRE / June 3, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) and Altus Formulation Inc. ("Altus") today announced the launch of TALLC Corporation ...

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT - the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies ...

Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...

BOSTON & BALLERUP, Denmark--(BUSINESS WIRE)--Elektrofi, Inc., a Boston-based biotechnology company focused on drug formulation and delivery innovations, and LEO Pharma A/S, a global leader in medical ...

MELBOURNE, Australia, Sept. 28, 2025 (GLOBE NEWSWIRE) -- CLINUVEL today announced that it is advancing new sustained-release liquid drug formulations in a preclinical program evaluating various drug ...

Greenville, NC, October 09, 2010 --(PR.com)-- Joseph E. "Joe" Cobb Jr., senior formulations scientist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional TM ...

The February 2026 meeting of the EMA's Committee for Medicinal Products for Human Use (CHMP) resulted in recommendations for twelve new medicines.¹ These outcomes, which included recommendations for ...

This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions ...

(RTTNews) - Biohaven Pharmaceutical Holding Company Ltd. (BHVN) announced the FDA has authorized the initiation of clinical trials for oral zavegepant. Biohaven Pharma said it has achieved first in ...